Page last updated: 2024-10-30

meclofenoxate and Cognition Disorders

meclofenoxate has been researched along with Cognition Disorders in 3 studies

Meclofenoxate: An ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Predescu, V1
Riga, D1
Riga, S1
Turlea, J1
Bărbat, IM1
Botezat-Antonescu, L1
Eichenberger, M1
Koiwa, M1
Okochi, Y1
Ueno, K1
Owada, T1
Kashiba, T1

Trials

1 trial available for meclofenoxate and Cognition Disorders

ArticleYear
Antagonic-stress. A new treatment in gerontopsychiatry and for a healthy productive life.
    Annals of the New York Academy of Sciences, 1994, Jun-30, Volume: 717

    Topics: Aged; Aging; Cognition Disorders; Double-Blind Method; Drug Combinations; Female; Humans; Male; Mecl

1994

Other Studies

2 other studies available for meclofenoxate and Cognition Disorders

ArticleYear
[Clinical experience with centrophenoxine (Lucidril) in internal medicine].
    Praxis, 1967, Jul-20, Volume: 56, Issue:29

    Topics: Acetates; Aged; Central Nervous System Stimulants; Cognition Disorders; Female; Humans; Male; Meclof

1967
[Clinical use of Lucidril in conscious disorders].
    Geka chiryo. Surgical therapy, 1970, Volume: 22, Issue:5

    Topics: Acetates; Adolescent; Adult; Aged; Central Nervous System Stimulants; Child; Cognition Disorders; El

1970